Press Releases

Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal

Go to article

Aurion Biotech Named “Regenerative Therapeutics Company Of The Year” By BioTech Breakthrough

Go to article

The Importance of Teamwork

Go to article

Aurion Biotech Announces First Subject Dosed in U.S. Phase 1 / 2 Clinical Trial

Go to article

Aurion Biotech Wins Clinical Advance of the Year Award at Biotech Week Boston

Go to article

Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Go to article

March Milestone

Go to article

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

Go to article

Jonathan Sparks, JD, PhD Joins Aurion Biotech as Chief Legal Officer

Go to article

Aurion Biotech Expands Its Leadership Team

Go to article

Aurion Biotech Wins Prestigious Prix Galien Startup Award

Go to article

Living Our Values at Aurion Biotech

Go to article

A Culture of Curiosity and Collaboration

Go to article

Summer Solstice or Mid-year Madness? 

Go to article

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

Go to article

Aurion Biotech Wins ASCRS Eyecelerator Award

Go to article

AURION BIOTECH RAISES $120 MILLION FROM DEERFIELD, PETRICHOR, FLYING L PARTNERS, FALCON VISION/KKR AND VISIONARY VENTURES

Go to article

Greg Kunst Appointed CEO of Aurion Biotech

Go to article

Why I Joined Aurion Biotech

Go to article

Aurion Biotech Wins “Best in Show” at AAO Eyecelerator Conference

Go to article

Aurion Biotech Announces Medical Advisory Board

Go to article

Aurion Biotech Announces Strategic Investments in Manufacturing

Go to article

Aurion Biotech Announces IOTA Cell Therapy Trial

Go to article

Planes, Trains and…Hurricanes?

Go to article

Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical Advisory Board

Go to article

Aurion Biotech Names Edward Holland, MD, Chair of Medical Advisory Board

Go to article

What Drive Success? A Conversation with Dr. Edward Holland

Go to article

Arnaud Lacoste Joins Aurion Biotech as Chief Scientific Officer

Go to article

When We Reach the End of What We Should Know

Go to article

In the News

The Ophthalmologist: Innovative Cell Therapies in Ophthalmology

Go to article

WIO: Aurion Cell Therapy: Consistency Across Multiple Clinical Trials

Go to article

Healio: Aurion Wins Prestigious Prix Galien Award

Go to article

EyeWorld: Aurion Biotech Receives Best in Show

Go to article

The Ophthalmologist: Cracking the Cornea Conundrum

Go to article

BIoSpace: Aurion Raises $120 Million to Advance Cell Therapy Platform

Go to article

BioWorld: Aurion Victorious with Vyznova Cell Therapy Approval in Japan

Go to article

Forbes: Innovation Rx

Go to article

Optometry Times: Cell Therapy for Corneal Endothelial Disease Gains Traction

Go to article

Corneal Physician: What's New in Eye Banking

Go to article

Ophthalmology Times: Innovations in the Treatment of Corneal Dystrophies

Go to article

Ophthalmology 360: Conversation with Dr. Matt Giegengack

Go to article

Ophthalmology Times: Jumping into Cell Therapy with Collaboration, Innovation

Go to article

Genetic Engineering & Biotechnology News: Aurion Biotech Industrializing Ophthalmologic Cell-Based Therapy

Go to article

BioSpace: How You React Now Determines Your Next Success

Go to article

Ophthalmology Times: Exploratory Trials in Cell Therapy

Go to article

The New England Journal of Medicine: Injection of Cultured Cells With a ROCK Inhibitor for Bullous Keratopathy

Go to article

AAO Ophthalmology Journal: Five-Year Follow-up...Cultured Corneal Endothelial Cells

Go to article

Corneal Physician: Injectable Corneal Endothelial Cells

Go to article

JAMA Ophthalmology: Global Survey of Corneal Transplantation & Eye Banking

Go to article